Upcoming Allied Market Research
Preclinical Imaging Market

Preclinical Imaging Market: Global Opportunity Analysis and Industry Forecast, 2022-2029 Market

Report Code: A07512
Pages: NA
Nov 2022 | 1021 Views
Author(s) : NA
Tables: NA
Charts: NA
  • Formats*:

  • Single User License, Five User
    License & Enterprise User License

  • Data Pack Excel License

  • It comes with the additional cost
    of $2500.00 contact sales.



Pandemic disrupted the entire world and affected many industries.

Get detailed COVID-19 impact analysis on the Preclinical Imaging Market

Request Now !

Preclinical imaging market is expected to witness growth in upcoming years due to factors such as advancements made in technology of molecular imaging modalities and increase in acceptance for preclinical imaging as an authorized drug development tool.


Preclinical imaging is the diagnosis and visualization carried out in animals for research activities such as drug development. Imaging system is important for the researchers to observe changes in animals especially in organ, tissue or molecular level. Imaging modalities which are in-vivo and non-invasive are important for studying animal models. Methods such as magnetic resonance imaging (MRI), CT (Computed Tomography, and high frequency micro ultrasound are also used in anatomical imaging. At the time of optical imaging (fluorescence and bio-luminescence), positron emission photography (PET) and single photon emission computed tomography (SPECT) are very important for molecular visualizations. Preclinical imaging is useful in observing the treatment reaction for early signs of effectiveness.


COVID-19 scenario analysis:

To take care of infected population, the demand for medical supplies is increasing. Respiratory support devices such as atomizer, life-support machine, oxygen generator, and monitor are among the majorly used medical devices in primary clinical treatment. Moreover, COVID-19 has led to a huge surge in demand for medical supplies such as personal protective equipment including masks, gloves, and protective eyeglasses. With rise in number of COVID-19 cases worldwide, the need for medical supplies keeps on rising among, both from healthcare professionals and civil population for precautionary measures. Manufacturers of these products have a chance to capitalize this increased demand of medical supplies to ensure adequate and continuous supply of personal protective equipment in the market. Considering these factors, COVID -19 is expected to have significant impact on the preclinical imaging market.

Top Impacting factors:

  • Factors such as advancements made in technology and rise in prevalence of chronic diseases such as cancer, rheumatoid arthritis, cardiovascular and neurological disorders are expected to drive the market growth globally.
  • Increasing demand for non- invasive imaging methods and rise in funding by the government is expected to boost the market growth.
  • However, factors such as high price associated with the imaging devices and limited number of applications in each modality is expected to hinder the growth for preclinical imaging market up to some extent over the forecast period.
  • Stringent rules and regulations for governing pre -clinical research & technological and procedural restrictions will hamper the market growth to some extent.

New Product Launch / News:

  • In June 2020, First National Preclinical Imaging Centre was established in Ireland to enhance medical research. This National Preclinical Imaging Centre (NPIC) which will provide enhanced research data to inform new clinical trials that aim to improve patient outcomes, was allocated funding of USD 3.8 million under the Science Foundation Ireland (SFI) Research Infrastructure Programme.
  • In 2020, Sartorius launched the new Incucyte SX5 Live-Cell Analysis System with new capabilities, including novel optics, a new line of paired reagents, and purpose-built software to help enable researchers to gain greater insight from live cell experiments
  • In 2019, Bruker, announced the launch of the Luxendo TruLive 3D Imager light-sheet imaging system. The new system features dual-sided illumination and highly efficient light collection for fast imaging of a broad range of biological samples in their native 3D environments.???????

Key benefits of the report:

  • This study presents the analytical depiction of the preclinical imaging market along with the current trends and future estimations to determine the investments.
  • The report presents information related to key drivers, restraints, and opportunities along with detailed analysis of the preclinical imaging market share.
  • The current market is quantitatively analyzed from 2020 to 2027 to highlight the market growth scenario.
  • Porter’s five forces analysis illustrates the potency of buyers & suppliers in the market. 
  • The report provides a detailed preclinical imaging market analysis based on competitive intensity and how the competition will take shape in coming years. 

Questions answered in the Preclinical Imaging Market Report: 

  • What are the leading market players active in Preclinical Imaging Market?
  • What the current trends will influence the market in the next few years?
  • What are the driving factors, restraints, and opportunities in the market?
  • What are the projections for the future that would help in taking further strategic steps?
  • What Segments and region will drive the preclinical imaging market growth & why?

Preclinical Imaging Market: Global Opportunity Analysis and Industry Forecast, 2020–2027 Report Highlights

Aspects Details
By Modality
  • Optical Imaging Systems
    • Optical + X-Ray/Optical + CT
    • Standalone Fluorescence Imaging Systems
    • Bioluminescence/Fluorescence Imaging Systems
  • Preclinical Nuclear Imaging Systems
    • Micro-PET Systems
    • Micro-SPECT Systems
    • Trimodality (SPECT/PET/CT) Systems
  • Micro-Ultrasound Systems
  • Micro-MRI Systems
  • Micro-CT Systems
  • Preclinical Photoacoustic Imaging Systems
  • Preclinical Magnetic Particle Imaging (MPI) Systems
By Reagents
  • Preclinical Optical Imaging Reagents
    • Fluorescent Imaging Reagents
    • Bioluminescent Imaging Reagents
  • Preclinical Nuclear Imaging Reagents
    • Preclinical PET Tracers
    • Preclinical SPECT Probes
  • Preclinical MRI Contrast Agents
    • Gadolinium-based Preclinical MRI Contrast Agents
    • Iron-based Preclinical MRI Contrast Agents
    • Manganese-based Preclinical MRI Contrast Agents
  • Preclinical Ultrasound Contrast Agents
  • Preclinical CT Contrast Agents
    • Gold Nanoparticles
    • Gastrografin-based Preclinical CT Contrast Agents
    • Iodine-based Preclinical CT Contrast Agents
    • Barium-based Preclinical CT Contrast Agents
By Region
  • North America  (US, Canada, Mexico)
  • Europe  (Germany, France, UK, Spain, Italy, rest of Europe)
  • Asia-Pacific  (China, India, Japan, Australia, rest of Asia-Pacific)
  • LAMEA  (Brazil, South Africa, Saudi Arabia, rest of LAMEA)
Key Market Players PerkinElmer, Bruker Corporation, FUJIFILM Holdings Corporation, Mediso Ltd, MILabs B.V, MR Solutions, LI-COR Biosciences, Aspect Imaging, TriFoil Imaging, Miltenyi Biotech GmbH, Berthold Technologies, Hitachi Medical, Agilent Technologies, Naviscan.

Loading Table Of Content...

With collective industry experience of about 200 years of its analysts and experts, Allied Market Research (AMR) encompasses most infallible research methodology for its market intelligence and industry analysis. We do not only engrave the deepest levels of markets but also sneak through its slimmest details for the purpose of our market estimates and forecasts. Our approach helps in building greater market consensus view for size, shape and industry trends within each industry segment. We carefully factor in industry trends and real developments for identifying key growth factors and future course of the market. Our research proceeds are the resultant of high quality data, expert views and analysis and high value independent opinions. Our research process is designed to deliver balanced view of the global markets and allow stakeholders to make informed decisions.

We offer our clients exhaustive research and analysis based on wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics and regional intelligence. Our in-house industry experts play instrumental role in designing analytic tools and models, tailored to the requirements of particular industry segment. These analytical tools and models sanitize the data & statistics and enhance the accuracy of our recommendations and advice. With AMR’s calibrated research process and 360` degree data-evaluation methodology, our clients are assured of receiving:

  • Consistent, valuable, robust and actionable data & analysis that can easily be referenced for strategic business planning
  • Technologically sophisticated and reliable insights through well audited and veracious research methodology
  • Sovereign research proceeds that present a tangible depiction of marketplace

With a strong methodology we are, therefore, confident that our research and analysis are most reliable and guarantees sound business planning.

Secondary research
We refer a broad array of industry sources for our secondary, which typically include; however, not limited to: Company SEC filings, annual reports, company websites, broker & financial reports and investor presentations for competitive scenario and shape of the industry

  • Patent and regulatory databases for understanding of technical & legal developments
  • Scientific and technical writings for product information and related preemptions
  • Regional government and statistical databases for macro analysis
  • Authentic new articles, web-casts and other related releases for market evaluation
  • Internal and external proprietary databases, key market indicators and relevant press releases for market estimates and forecast

Primary research
Our primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks and face-to-face interactions. We are also in professional corporate relations with various companies that allow us greater flexibility for reaching out industry participants and commentators for interviews and discussions, fulfilling following functions:

  • Validates and improves the data quality and strengthens research proceeds
  • Further develops analyst team’s market understanding and expertise
  • Supplies authentic information about market size, share, growth and forecasts

Our primary research interview and discussion panels are typically composed of most experienced industry members. These participants include; however, not limited to:

  • Chief executives and VPs of leading corporations specific to industry
  • Product and sales managers or country heads; channel partners and top level distributors; banking, investments and valuation experts Key opinion leaders (KOLs)

Analyst tools and models
AMR has developed set of analyst tools and data models to supplement and expedite the analysis process. Corresponding to markets, where there is significant lack of information and estimates, AMR’s team of experts and analyst develop specific analyst tools and industry models to translate qualitative and quantitative industry indicators into exact industry estimates. These models also allow analysts to examine the prospects and opportunities prevailing in the market to accurately forecast the course of the market.

Call or Email us

U.S.-Canada Toll-free: +1-800-792-5285
Int'l : +1-503-894-6022
Europe : + 44-845-528-1300
Email : help@alliedmarketresearch.com

Looking for Customization?

 Customization Request

Have a Question?

 Speak with Analyst

Any Confusion?

 Inquire Before Buying

Have a glance of the Report

  Enquiry Now

Purchase Full Report of
Preclinical Imaging Market

Start reading.
This Report and over 19,320+ more Reports, Available with Avenue Library. T&C*.

  • Online Only
  • $3,690
  • Online cloud access only
  • Restricted print, copy, paste & download
  • Read only
  • Free industry update
    (Within 180 days)
  • Free report update in next update cycle
  • Data Pack
  • $3,840
  • Restricted to one authorized user
  • One print only
  • Available in
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle
  • Single User
  • $5,820
  • Restricted to one authorized user
  • One print only
  • Available in
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle
  • Five Users
  • $6,540
  • Limited to five authorized users
  • Print upto five copies
  • Available in
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle
  • Enterprise

  • $9,870
  • Unlimited
  • Available in Excel & PDF
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle
  • Library

  • $ 999
    Per User/ Per month/ Billed annually
  • Published Content
  • Company Profiles
  • Newly Added Content Access
  • 10 PDF
  • 5 Excel Data
    Pack Downloads
  • 250 Company Profiles PDF Downloads
  • Buy Now

*Taxes/Fees, if applicable will be added during checkout. All prices in USD


Why Allied Market Research?


Infallible Methodology

To ensure high-level data integrity, accurate analysis, and impeccable forecasts

Analyst Support

For complete satisfaction


On-demand customization of scope of the report to exactly meet your needs


Targeted market view to provide pertinent information and save time of readers

Get fresh content delivered

Get insights on topics that are crucial for your business. Stay abreast of your interest areas.

Get Industry Data Alerts

Why Allied Market Research?

Infallible Methodology

To ensure high-level data integrity, accurate analysis, and impeccable forecasts

Analyst Support

For complete satisfaction


On-demand customization of scope of the report to exactly meet your needs


Targeted market view to provide pertinent information and save time of readers